Jumpcode Genomics
Mike Salter serves as President and CEO of Jumpcode Genomics since July 2023 and is currently a Non Executive Director at Trellus Health since May 2021. Prior roles include CEO of EKF Diagnostics for the Americas and various leadership positions at GE Healthcare, where responsibilities encompassed managing a global business unit and overseeing custom molecular biology products. Mike's extensive career at GE Healthcare began in 1984, culminating in roles such as Global Senior Product Marketing Manager. Mike holds a GRSC HONS degree in Chemistry from the University of Wales, attained between 1983 and 1986.
This person is not in any teams
Jumpcode Genomics
Jumpcode Genomic's patented technology unlocks the power of Next Generation Sequencing by improving sensitivity, reducing costs, simplifying workflows, and removing bias. Researchers around the world are using our CRISPRClean technology in the fields of infectious disease, oncology, consumer genomics, food science, and basic research.